HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chemical synthesis and characterization of conjugates of a novel catechol-O-methyltransferase inhibitor.

Abstract
BIA 3-202, 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone 3, is a novel, reversible, and tight-binding peripheral inhibitor of the enzyme catechol-O-methyltransferase (COMT), which is currently under clinical evaluation for the treatment of Parkinson's disease as an adjunct to current L-Dopa/peripheral decarboxylase inhibitor therapy. Chemically pure, well-characterized reference standards of conjugates of 3 were required for investigation of the routes of metabolism in several animal species (including humans) and for pharmacokinetic studies. The lack of suitable literature precedents for efficient, regioselective synthesis of nitrocatechol conjugate metabolites prompted us to develop efficient and highly selective chemical preparations of O-glucuronide and O-sulfate conjugates of 3 such that multigram quantities of excellent purity can now be conveniently synthesized. It is anticipated that these procedures could be applied to the synthesis of conjugates of other COMT inhibitors, also based on the 3-nitrocatechol pharmacophore.
AuthorsDavid A Learmonth, Ana P Freitas
JournalBioconjugate chemistry (Bioconjug Chem) 2002 Sep-Oct Vol. 13 Issue 5 Pg. 1112-8 ISSN: 1043-1802 [Print] United States
PMID12236793 (Publication Type: Journal Article)
Chemical References
  • Acetophenones
  • Antiparkinson Agents
  • Catechol O-Methyltransferase Inhibitors
  • Catechols
  • Enzyme Inhibitors
  • nebicapone
Topics
  • Acetophenones
  • Animals
  • Antiparkinson Agents (chemical synthesis, chemistry)
  • Catechol O-Methyltransferase Inhibitors
  • Catechols (chemical synthesis)
  • Enzyme Inhibitors (chemical synthesis, chemistry)
  • Humans
  • Reference Standards

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: